Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients
Type 2 diabetes is often associated with arterial atherosclerosis in large blood vessels. We set out to elucidate whether commonly used antidiabetic drugs metformin, sitagliptin, and pioglitazone will reduce atherosclerosis in T2DM patients. We enrolled 176 individuals with type 2 diabetes, which we...
Saved in:
| Main Authors: | Xiaojie Liu, Tao Mei, Wei Chen, Shandong Ye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2017/5032708 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Which antidiabetic drugs do patients of T2DM prefer in India and why? A discrete choice experiment
by: Shrutangi Vaidya, et al.
Published: (2024-11-01) -
Antidiabetic medication use during pregnancy: an international utilization study
by: Øystein Karlstad, et al.
Published: (2019-05-01) -
Adherence to the treatment with oral antidiabetic medications in primary health care
by: Andréa Pereira da Silva, et al.
Published: (2015-06-01) -
Adherence to the treatment with oral antidiabetic medications in primary health care
by: Andréa Pereira da Silva, et al.
Published: (2015-06-01) -
Circulating miR-4454 as a potential biomarker for the diagnosis of T2DM and the prediction value of comorbidity and complications in T2DM
by: Song Yang, et al.
Published: (2025-06-01)